Diagnostic Value of Serum Clara Cell Secretory Protein Level in an Experimental Blunt Chest Trauma Model
Öz
Objective: Blunt chest trauma is a significant clinical problem leading to injury of the lungs that may be fatal. Experimental blunt chest trauma is well established in animal models. This study aimed to investigate whether Clara cell secretory protein (CC16) can be a biomarker in an experimentally created blunt chest trauma model.
Material and Methods: A total of 30 rabbits were used in our study. A modified bilateral blunt thoracic trauma model was used to produce different levels of lung contusion. We divided the rabbits into four groups according to the energy level at which blunt thoracic trauma was applied. Blood samples were taken from the control and trauma groups to evaluate CC16 levels at 0, 12, and 24 hours.
Results: The CC16 levels measured at the start of the experiment were significantly lower in the control and low-energy groups compared to the medium- and high-energy groups (p =.002). While there was a significant difference in CC16 levels measured at the 12th hour (p =.004), no significant difference was found among the groups at the 24th hour. Upon analyzing the change in CC16 levels over time within the groups, we observed that CC16 levels decreased from 0–12 hours and subsequently increased after the 12th hour. Histopathologically, we observed that the level of contusion increased in proportion to the severity of trauma across the different groups.
Conclusion: With the designed platform, we created a reproducible experimental model of pulmonary contusion from blunt thoracic trauma in rabbits. Increased levels of CC16 following a lung contusion could serve as a foundation for clinical decision-making. Thus, CC16 has the potential to serve as a rapid and simple biochemical indicator for acute traumatic lung injury.
Anahtar Kelimeler
Kaynakça
- Dogrul BN, Kiliccalan I, Asci ES, Peker SC. Blunt trauma related chest wall and pulmonary injuries: An overview. Chin J Traumatol 2020; 23(3): 125-138. doi: 10.1016/j.cjtee.2020.04.003. PMID: 32417043.
- Yadollahi M, Arabi AH, Mahmoudi A, Zamani M, Farahmand M. Blunt Thoracic Injury Mortality and Clinical Presentation. Trauma Mon 2018; 23(4): e13079. doi: 10.5812/traumamon.13079.
- Miller PR, Croce MA, Bee TK, Qaisi WG, Smith CP, Collins GL, et al. ARDS after pulmonary contusion: accurate measurement of contusion volume identifies high-risk patients. J Trauma 2001; 51(2): 223-230. doi: 10.1097/00005373-200108000-00003. PMID: 11493778.
- Yamamoto L, Schroeder C, Morley D, Beliveau C. Thoracic trauma: the deadly dozen. Crit Care Nurs Q. 2005; 28(1): 22-40. doi: 10.1097/00002727-200501000-00004. PMID: 15732422.
- Fremont RD, Koyama T, Calfee CS, Wu W, Dossett LA, Bossert FR, et al. Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma 2010; 68(5): 1121-1127. doi: 10.1097/TA.0b013e3181c40728. PMID: 20038857.
- Johnson ER, Matthay MA. Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv 2010; 23(4): 243-252. doi: 10.1089/jamp.2009.0775. PMID: 20073554.
- Hudson LD, Steinberg KP. Epidemiology of acute lung injury and ARDS. Chest. 1999;116(1 Suppl): 74S-82S. doi: 10.1378/chest.116.suppl_1.74s-a. PMID: 10424602.
- Cohn SM, Zieg PM. Experimental pulmonary contusion: review of the literature and description of a new porcine model. J Trauma 1996; 41(3): 565-571. doi: 10.1097/00005373-199609000-00036. PMID: 8810987.
- Cohn SM. Pulmonary contusion: review of the clinical entity. J Trauma 1997; 42(5): 973-979. doi: 10.1097/00005373-199705000-00033. PMID: 9191684.
- Broeckaert F, Bernard A. Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy. 2000; 30(4): 469-475. doi: 10.1046/j.1365-2222.2000.00760.x. PMID: 10718843.